Different studies have identified different candidate genes, it also appears that schizophrenia is aetiologicallyheterogeneous, i.e. different combinations of factors can lead to the condition
Ripke et al (2014) carried out a huge study comparing the genetic make-up of 37,000 patients to 113,000 controls, 108 separate genetic variations were associated with increased risk of schizophrenia
Positive correlations between paternal age (associated with increased risk of sperm mutation) and risk of schizophrenia, increasing from 0.7% with fathers under 25 to over 2% in fathers over 50 (Brown et al 2002)
Gottesman (1991) shows how genetic similarity and the shared risk of getting schizophrenia are related
Adoption studies such as the one by Tienari et al (2004) show that children of schizophrenia sufferers are still at heightened risk of schizophrenia if adopted into families with no history of schizophrenia
Ripke et al (2014) found that particular genetic variations significantly increase the risk of schizophrenia
Research shows that 67% of people with schizophrenia and related psychotic disorders reported at least one childhood trauma, opposed to 38% of a matched group with non-psychotic mental health issues
The risk estimate is just an average figure, it will not really reflect the probability of a particular child going on to develop schizophrenia because they will experience a particular environment which also has risk factors
Abnormal dopamine systems in the brain's cortex, with low levels of dopamine (hypodopaminergia) in the prefrontal cortex being linked to the negative symptoms of schizophrenia
Dopamine agonists like amphetamines that increase the levels of dopamine make schizophrenia worse and can produce schizophrenia like symptoms in non-sufferers (Curren et al 2004)
Antipsychotic drugs work by reducing dopamine activity (Tauscher et al 2014)
There is also evidence that suggests that dopamine does not provide a complete explanation for schizophrenia, as some of the genes identified code for the production of other neurotransmitters
Evidence for the dopamine hypothesis is mixed, it may be that both hyper and hypodopaminergia are correct explanations, both high and low levels of dopamine in different brain regions are involved in schizophrenia – different for different people
Live brain scans and post-mortems have consistently found raised levels of glutamate in several areas of the brain in people with schizophrenia, and several candidate genes are thought to be responsible for glutamate production or processing
Tenn et al (2003) induced schizophrenia-like symptoms in rats using amphetamines and then relieved symptoms using drugs that reduce DA action
However, other drugs that increase DA do not cause schizophrenia like symptoms, and Garson (2017) has challenged the idea that amphetamine psychosis closely mimics schizophrenia